Literature DB >> 2027145

An audit of surgical treatment of ovarian cancer in a metropolitan health region. Association of Obstetricians and Gynaecologists of the North East Thames Region.

C N Hudson1, P Potsides, O M Curling.   

Abstract

The varied application of surgery to the initial treatment of 908 cases of primary ovarian cancer is analysed. In patients with advanced disease (FIGO Stages IIb, III and IV) 256 (46%) of 555 women achieved minimal residual disease status by primary surgery and this proportion fell to 24% when only stages III and IV were considered; of these cases 7% underwent adjunctive intestinal resection or urinary tract surgery. Although not in a clinical trial situation the women achieving minimal residual disease status before chemotherapy survived better in the short term, although long-term survival remained disappointing. In early disease 3% of young women have been subjected to hysterectomy and removal of both ovaries. By contrast, in 16% of women over the age of 40 years with early ovarian cancer bilateral oophorectomy was not carried out.

Entities:  

Mesh:

Year:  1991        PMID: 2027145      PMCID: PMC1293183          DOI: 10.1177/014107689108400408

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  10 in total

1.  A radical operation for fixed ovarian tumours.

Authors:  C N Hudson
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-11

2.  The role of bowel surgery in the primary treatment of epithelial ovarian cancer.

Authors:  R H Hammond; C R Houghton
Journal:  Aust N Z J Obstet Gynaecol       Date:  1990-05       Impact factor: 2.100

3.  Debunking debulking.

Authors:  G E Moore
Journal:  Surg Gynecol Obstet       Date:  1980-03

4.  Victor Bonney Lecture, 1980. Ovarian cancer--a gynaecological disorder?

Authors:  C N Hudson
Journal:  Ann R Coll Surg Engl       Date:  1981-03       Impact factor: 1.891

Review 5.  Cytoreduction in ovarian cancer: achievability and results.

Authors:  M J Webb
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1989-03

6.  Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity.

Authors:  A P Heintz; N F Hacker; J S Berek; T P Rose; A K Munoz; L D Lagasse
Journal:  Obstet Gynecol       Date:  1986-06       Impact factor: 7.661

7.  Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer.

Authors:  J S Berek; N F Hacker; L D Lagasse
Journal:  Obstet Gynecol       Date:  1984-11       Impact factor: 7.661

8.  Primary cytoreductive surgery for epithelial ovarian cancer.

Authors:  N F Hacker; J S Berek; L D Lagasse; R K Nieberg; R M Elashoff
Journal:  Obstet Gynecol       Date:  1983-04       Impact factor: 7.661

9.  Incidence of subclinical metastasis in stage I and II ovarian carcinoma.

Authors:  M S Piver; J J Barlow; S B Lele
Journal:  Obstet Gynecol       Date:  1978-07       Impact factor: 7.661

10.  Intestinal surgery in gynaecological oncology.

Authors:  M J Webb; E W Weaver
Journal:  Aust N Z J Obstet Gynaecol       Date:  1987-11       Impact factor: 2.100

  10 in total
  1 in total

1.  Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

Authors:  M Curling; S Stenning; C N Hudson; J V Watson
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.